ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $13,000 | +550.0% | 1,100 | +1000.0% | 0.00% | – |
| Q2 2018 | $2,000 | -99.1% | 100 | -99.4% | 0.00% | -100.0% |
| Q1 2018 | $211,000 | +7.7% | 17,400 | +1.8% | 0.05% | +18.2% |
| Q4 2017 | $196,000 | -22.2% | 17,100 | -17.0% | 0.04% | -21.4% |
| Q3 2017 | $252,000 | -57.1% | 20,600 | -59.8% | 0.06% | -34.9% |
| Q2 2017 | $587,000 | +46.4% | 51,300 | +165.8% | 0.09% | +87.0% |
| Q1 2017 | $401,000 | +1385.2% | 19,300 | +1384.6% | 0.05% | +1433.3% |
| Q4 2016 | $27,000 | -90.2% | 1,300 | -84.5% | 0.00% | -91.4% |
| Q3 2016 | $275,000 | – | 8,400 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |